Ondansetron vs Trenbolone
FDA Approved vs Moderate Research
avoid Mechanism-based · 64% Both Ondansetron and Trenbolone carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.
Molecular Data
Ondansetron Trenbolone
Weight 293.36 Da 270.37 Da (base)
Half-life ~4 hours ~3 days (acetate)
Type Carbazole derivative (C18H19N3O) 19-nortestosterone derivative (C18H22O2), trienone steroid
Key Benefits
Ondansetron
01 Highly effective at controlling nausea and vomiting from a wide range of causes, including GLP-1 agonists, HCG, and nandrolone
02 Orally disintegrating tablet (ODT) dissolves on the tongue in seconds, ideal for use during active nausea when swallowing pills is difficult
03 Does not cause sedation, extrapyramidal symptoms, or prolactin elevation, unlike dopamine-blocking anti-emetics
04 Fast onset of action (15-30 minutes oral, near-immediate for ODT) with reliable 4-8 hour duration
05 Well-tolerated with a mild side effect profile at standard doses
06 Widely available as an inexpensive generic in multiple formulations
Trenbolone
01 Exceptional lean muscle mass accrual with minimal water retention due to non-aromatizing profile
02 Dramatic body recomposition capability -- simultaneous muscle gain and fat loss even in caloric deficit
03 Approximately five times the anabolic and androgenic potency of testosterone (500:500 ratio)
04 Powerful anti-catabolic effects through glucocorticoid receptor antagonism, protecting muscle during dieting
05 Significant increases in strength across all compound movements, often rapid in onset
06 Enhanced nutrient partitioning, directing calories toward lean tissue accretion over fat storage
07 Pronounced muscle hardness, density, and vascularity due to absence of estrogenic water retention
08 Increased IGF-1 production in muscle tissue, amplifying growth signaling pathways
Dosing Protocols
Ondansetron
4-8 mg as needed / Up to 3 times daily
Trenbolone
200-400 mg/week / Every other day (acetate) or 2x per week (enanthate)
Recomposition - Moderate (Acetate) 200-300 mg/week (50-75 mg every other day) Every other day
Advanced Cutting (Acetate) 300-400 mg/week (75-100 mg every other day) Every other day
Lean Bulk (Enanthate) 200-400 mg/week 2x per week
Contest Preparation - Advanced 300-500 mg/week Every other day (acetate) or 2x per week (enanthate)
Side Effects
Ondansetron
Headache (most frequently reported side effect)
Constipation (5-HT3 blockade reduces gut motility)
Fatigue or dizziness
Dry mouth
Trenbolone
Insomnia and severely disrupted sleep architecture (one of the most universally reported side effects, affecting the majority of users)
Night sweats, often drenching, requiring sheet changes
Significantly reduced cardiovascular endurance and aerobic capacity
Increased aggression, irritability, and shortened temper
Anxiety and restlessness, particularly at higher doses
Tren cough: acute, intense coughing fit lasting 30-90 seconds immediately after injection, caused by a small amount of oil entering a blood vessel
Dark-colored urine (oxidized metabolites; not necessarily indicative of kidney damage but should be monitored)
Elevated body temperature and increased sweating throughout the day
Acne and oily skin, particularly on shoulders, back, and chest
Accelerated hair loss in those genetically predisposed to male pattern baldness
Profoundly suppressive of natural testosterone production (near-complete HPT axis shutdown)
Increased heart rate and elevated blood pressure
Contraindications
Known hypersensitivity to ondansetron or other 5-HT3 antagonists
Congenital long QT syndrome
Concurrent use of apomorphine (risk of severe hypotension and loss of consciousness)
Severe hepatic impairment (maximum dose should not exceed 8 mg/day)
First steroid cycle or limited anabolic steroid experience (trenbolone is strictly an advanced-only compound)
Pre-existing cardiovascular disease, cardiomyopathy, or significant cardiac risk factors
History of mental health conditions: anxiety disorders, depression, bipolar disorder, or psychotic episodes
Liver disease or significantly elevated liver enzymes
Kidney disease or impaired renal function
Uncontrolled hypertension
Polycythemia (hematocrit above 54% at baseline)
Prostate cancer or history of hormone-sensitive cancers
Active or recent substance abuse (trenbolone's psychological effects can exacerbate addictive behaviors)
Pregnancy or potential for pregnancy in female partners (extremely virilizing compound)
Research Evidence
Ondansetron Trenbolone
Status FDA Approved Moderate Research
References 4 studies 5 studies
Latest — January 2023
FDA Approved Yes No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.